Safety, Efficacy, and Durability of Outcomes: Results from SECURE: A Single Arm, Multicenter, Prospective, Clinical Study on a Minimally Invasive Posterior Sacroiliac Fusion Allograft Implant
Journal of Pain Research2024Vol. Volume 17, pp. 1209–1222
Citations Over TimeTop 10% of 2024 papers
Aaron Calodney, Nomen Azeem, Patrick Buchanan, Ioannis Skaribas, Ajay Antony, Christopher Kim, George Girardi, Chau Vu, Christopher Bovinet, Rainer Vogel, Sean Li, Navdeep Jassal, Youssef Josephson, Timothy R. Lubenow, Christopher Lam, Timothy R. Deer
Abstract
These results suggest that the posterior approach LinQ Implant System is a safe and effective treatment for sacroiliac joint dysfunction at 12 months, with results that are favorable compared to outcomes reported for an FDA-cleared lateral approach.
Related Papers
- → Is Fluoroscopy Necessary for Sacroiliac Joint Injections?(2003)79 cited
- → Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial(2012)75 cited
- → Regulatory challenges and investigational device exemption protocols for fenestrated and branched EVAR in the United States(2022)3 cited
- → The First Year after FDA Approval of the CHARITÉ Artificial Disc: “Real World” Adverse Events Outside an Investigational Device Exemption Study Environment(2006)1 cited
- → Results of the Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc®-L Total Disc Replacement Versus Circumferential Fusion for the Treatment of 1-Level Degenerative Disc Disease(2008)